Multiple Choice
_____ is the most significant neurotransmitter target when treating schizophrenia.
A) GABA
B) 5-HT
C) Glutamate
D) DA
Correct Answer:

Verified
Correct Answer:
Verified
Q3: Why would a slow-release depot formulation be
Q4: What neurotransmitter is not associated with schizophrenia?<br>A)Acetylcholine<br>B)Glutamate<br>C)Cholecystokinin<br>D)Serotonin
Q5: MATCHING<br>Match the following generic drug names with
Q6: Traditional neuroleptics block DA at postsynaptic receptor
Q7: Which of the following is thought to
Q9: Not all neuroleptic agents bind to dopamine
Q10: MATCHING<br>Match the following generic drug names with
Q11: Neuroleptic malignant syndrome (NMS)is a life-threatening side
Q12: Onset of schizophrenia typically occurs _.<br>A)after age
Q13: Which of the following is not used